Acknowledgement
Supported by : National Cancer Center, National Research Foundation of Korea (NRF)
References
- Basset, C., Bonnet-Magnaval, F., Navarro, M.G., Touriol, C., Courtade, M., Prats, H., Garmy-Susini, B., and Lacazette, E. (2017). Api5 a new cofactor of estrogen receptor alpha involved in breast cancer outcome. Oncotarget 8, 52511-52526. https://doi.org/10.18632/oncotarget.17281
- Boelaert, K., McCabe, C.J., Tannahill, L.A., Gittoes, N.J., Holder, R.L., Watkinson, J.C., Bradwell, A.R., Sheppard, M.C., and Franklyn, J.A. (2003). Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer. J Clin Endocrinol Metab 88, 2341-2347. https://doi.org/10.1210/jc.2002-021113
- Chlebova, K., Bryja, V., Dvorak, P., Kozubik, A., Wilcox, W.R., and Krejci, P. (2009). High molecular weight FGF2: the biology of a nuclear growth factor. Cell Mol Life Sci 66, 225-235. https://doi.org/10.1007/s00018-008-8440-4
- Cho, H., Chung, J.Y., Song, K.H., Noh, K.H., Kim, B.W., Chung, E.J., Ylaya, K., Kim, J.H., Kim, T.W., Hewitt, S.M., and Kim, J.H. (2014). Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer. BMC Cancer 14, 545. https://doi.org/10.1186/1471-2407-14-545
- de Almagro, M.C., and Vucic, D. (2012). The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anticancer therapy. Exp Oncol 34, 200-211.
- Dynek, J.N., and Vucic, D. (2013). Antagonists of IAP proteins as cancer therapeutics. Cancer Lett 332, 206-214. https://doi.org/10.1016/j.canlet.2010.06.013
- Fukui, S., Nawashiro, H., Otani, N., Ooigawa, H., Nomura, N., Yano, A., Miyazawa, T., Ohnuki, A., Tsuzuki, N., Katoh, H., Ishihara, S., and Shima, K. (2003). Nuclear accumulation of basic fibroblast growth factor in human astrocytic tumors. Cancer 97, 3061-3067. https://doi.org/10.1002/cncr.11450
- Garcia-Jove Navarro, M., Basset, C., Arcondeguy, T., Touriol, C., Perez, G., Prats, H., and Lacazette, E. (2013). Api5 contributes to E2F1 control of the G1/S cell cycle phase transition. PLoS One 8, e71443. https://doi.org/10.1371/journal.pone.0071443
- Han, B.G., Kim, K.H., Lee, S.J., Jeong, K.C., Cho, J.W., Noh, K.H., Kim, T.W., Kim, S.J., Yoon, H.J., Suh, S.W., Lee, S., and Lee, B.I. (2012). Helical repeat structure of apoptosis inhibitor 5 reveals protein-protein interaction modules. J Biol Chem 287, 10727-10737. https://doi.org/10.1074/jbc.M111.317594
- Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y., and Sakuragi, N. (2014). Apoptosis and molecular targeting therapy in cancer. Biomed Res Int 2014, 150845.
- Imre, G., Berthelet, J., Heering, J., Kehrloesser, S., Melzer, I.M., Lee, B.I., Thiede, B., Dotsch, V., and Rajalingam, K. (2017). Apoptosis inhibitor 5 is an endogenous inhibitor of caspase-2. EMBO Rep 18, 733-744. https://doi.org/10.15252/embr.201643744
- Krejci, P., Pejchalova, K., Rosenbloom, B.E., Rosenfelt, F.P., Tran, E.L., Laurell, H., and Wilcox, W.R. (2007). The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia. J Leukoc Biol 82, 1363-1364. https://doi.org/10.1189/jlb.0607425
- Matthews, B.W. (1968). Solvent content of protein crystals. J Mol Biol 33, 491-497. https://doi.org/10.1016/0022-2836(68)90205-2
- Mayank, A.K., Sharma, S., Nailwal, H., and Lal, S.K. (2015). Nucleoprotein of influenza A virus negatively impacts antiapoptotic protein API5 to enhance E2F1-dependent apoptosis and virus replication. Cell Death Dis 6, e2018.
- Morris, E.J., Michaud, W.A., Ji, J.Y., Moon, N.S., Rocco, J.W., and Dyson, N.J. (2006). Functional identification of Api5 as a suppressor of E2Fdependent apoptosis in vivo. PLoS Genet 2, e196. https://doi.org/10.1371/journal.pgen.0020196
- Otwinowski, Z., and Minor, W. (1997). Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276, 307-326.
- Rigou, P., Piddubnyak, V., Faye, A., Rain, J.C., Michel, L., Calvo, F., and Poyet, J.L. (2009). The antiapoptotic protein AAC-11 interacts with and regulates Acinus-mediated DNA fragmentation. EMBO J 28, 1576-1588. https://doi.org/10.1038/emboj.2009.106
- Sasaki, H., Moriyama, S., Yukiue, H., Kobayashi, Y., Nakashima, Y., Kaji, M., Fukai, I., Kiriyama, M., Yamakawa, Y., and Fujii, Y. (2001). Expression of the antiapoptosis gene, AAC-11, as a prognosis marker in non-small cell lung cancer. Lung Cancer 34, 53-57.
- Song, K.H., Kim, S.H., Noh, K.H., Bae, H.C., Kim, J.H., Lee, H.J., Song, J., Kang, T.H., Kim, D.W., Oh, S.J., Jeon, J.H., and Kim, T.W. (2015). Apoptosis Inhibitor 5 Increases Metastasis via Erk-mediated MMP expression. BMB Rep 48, 330-335. https://doi.org/10.5483/BMBRep.2015.48.6.139
- Tewari, M., Yu, M., Ross, B., Dean, C., Giordano, A., and Rubin, R. (1997). AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal. Cancer Res 57, 4063-4069.
- Van den Berghe, L., Laurell, H., Huez, I., Zanibellato, C., Prats, H., and Bugler, B. (2000). FIF [fibroblast growth factor-2 (FGF-2)-interacting-factor], a nuclear putatively antiapoptotic factor, interacts specifically with FGF-2. Mol Endocrinol 14, 1709-1724. https://doi.org/10.1210/mend.14.11.0556
- Vucic, D., and Fairbrother, W.J. (2007). The inhibitor of apoptosis proteins as therapeutic targets in cancer. Clin Cancer Res 13, 5995-6000. https://doi.org/10.1158/1078-0432.CCR-07-0729
- Zhu, X., Komiya, H., Chirino, A., Faham, S., Fox, G.M., Arakawa, T., Hsu, B.T., and Rees, D.C. (1991). Three-dimensional structures of acidic and basic fibroblast growth factors. Science 251, 90-93. https://doi.org/10.1126/science.1702556